Jazz Pharmaceuticals

Rylaze

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Rylaze – J9021

Manufacturer:

Jazz Pharmaceuticals

Name:

Rylaze

HCPCS Code Descriptor:

Injection, asparaginase, recombinant, (rylaze), 0.1 mg

Category:

J Code

HCPCS:

J9021

NDC(s):

68727-0900-01, 68727-0900-03

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intramuscular

About:

Rylaze is an Oncology drug manufactured by Jazz Pharmaceuticals and administered via the Intramuscular route of administration. The J Code: J9021 is aligned to the drug Rylaze.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/22

HCPCS Effective Date:

1/1/22

HCPCS Short Description:

Inj, aspara, rylaze, 0.1 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://jazzcares.com/